MOUNTAIN VIEW, California, March 30, 2023 /PRNewswire/ -- Turn Biotechnologies, a cell rejuvenation company developing new mRNA drugs to cure intractable age-related diseases, has announced that it will share for the first time new data from its groundbreaking dermatological platform with the international community of regenerative aesthetics.
Evidence-based data demonstrating the global regenerative efficacy of Turn Bio's Epigenetic Reprogramming of Aging (ERA™) technology in human skin cells will be shared at the World Congress on Aesthetics and Anti-Aging, the leading international conference specializing in regenerative aesthetic medicine. and anti-aging.
Turn Bio's Co-Founder and Research Director, Dr. Vittorio Sebastiano, will provide insight into stem cell depletion and discuss how the company's ERA™ technology can rejuvenate cells and restore cellular function in the skin. The workshop will take place on March 31, from 9:00 a.m. to 10:30 a.m. CET, at the Camille Blanc Auditorium at the Grimaldi Forum in Monaco.
Turn Bio's latest dermatology data will also be discussed in presentations by various dermatology opinion leaders during scientific sessions chaired by internationally renowned experts in the field.
ABOUT TURN BIOTECHNOLOGIES
Turn Bio is a preclinical company focused on tissue repair at the cellular level and the development of transformative drug delivery systems. The company's proprietary ERA™ (Epigenetic Reprogramming of Aging) mRNA platform technology restores optimal gene expression by combating the effects of aging in the epigenome. This restores the cells' ability to prevent or treat disease and heal or regenerate tissue. It will help fight incurable chronic diseases. Its eTurna™ delivery platform uses unique formulas to precisely deliver load to specific organs, tissues, and cell types.
The company is completing preclinical research on tailored therapies for indications in dermatology and immunology, and developing therapies for ophthalmology, osteoarthritis, and the muscular system. For more information visit the website at www.turn.bio.
FOR MORE INFORMATION CONTACT:
Jim Martinez, rightstorygroupjim@rightstorygroup.com or (312) 543-9026
Photo - https://mma.prnewswire.com/media/2043671...Logo - https://mma.prnewswire.com/media/1935529...
View original content: https://www.prnewswire.com/news-releases/turn-biotechnologies-presenta-su-plataforma-de-dermatologia-a-la-comunidad-estetica-europea-en-la-amwc-301785914.html
